Artisan Lab

Artisan Lab Co., Ltd. is a Japanese medical research and development company focused on addressing clinical challenges in dialysis, blood purification, and metabolic diseases. Founded in 2015 and headquartered in Tokyo, the company develops innovative medical devices and pharmaceutical candidates through collaborative research and patent commercialization. Artisan Lab's key achievements include a cationic cellulose-based hemostatic pad commercialized in partnership with Nipro Corporation, which significantly reduces post-dialysis bleeding time. The company is also developing a novel capped-needle device designed to eliminate air bubbles during hemodialysis. Additionally, in collaboration with the National Institute of Advanced Industrial Science and Technology (AIST) and Kobelco Eco-Solutions, Artisan Lab is researching a water-soluble cationic paramylon derivative derived from Euglena that promotes GLP-1 secretion for the treatment of obesity and type 2 diabetes.